source
- Ionis secures FDA approval for zilganersen, its first solo neurology therapy for Alexander diseaseIonis Pharmaceuticals announced that the U.S. Food and Drug Administration has granted approval to its investigational RNA‑based drug zilganersen for the treatment of Alexander disease, a rare neur…
- MassBio and SCbio select 10 life science startups for Drive acceleratorMassBio and SCbio announced that ten early‑stage life‑science companies have been chosen for the fall cohorts of the Drive accelerator program. The selection includes five biotech firms and five te…